No Detail Found!

Intermediate release formulations of diclofenac potassium tablets for IVIVC.

Author(s)
Huma Ali Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan; Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan
Muhammad Harris Shoaib Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan
Farya Zafar Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan
Rabia Bushra Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan
Riffat Yasmin Dow College of pharmacy, Dow University of Health Sciences (DUHS), Karachi, Pakistan
Shehla Siddiqui Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan
Zafar M Alam Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi, Karachi, Pakistan
Abstract
In recent days response surface methodology (RSM) has widely been applied for development and optimization of cost effective formulations with required quality. Study comprised of three steps including micromeritic comparison of different powder blends of placebo and diclofenac potassium (DP), formulation designing with CCRD (Design Expert, version 7.0.0), and stability testing of selected formulations by using R Gui. Ten formulations (F11-F20) were developed using microcrystalline cellulose (Avicel PH-102) (X1) (13-72%), methocel K15M (X2) (6.59-23.4%) and magnesium stearate (X3) (1.32-4.68%), while responses were % friability and % drug release. Blending rate constant was determined at 3, 6, 9 and 12 minutes. The results of physicochemical parameters were found within acceptable limits. After in vitro testing at pH 1.2, pH 4.5 and pH 6.8, mechanism of drug release, kinetic analysis and statistical evaluation were carried out by model - independent, model-dependent and one-way ANOVA methods. Most formulations followed zero order kinetics at higher pH. Fickian release (0.326≤ n ≤0.449) was observed with β greater than 0.5 and less than 1. ANOVA indicated no significant variation within and between formulations as p-values were found to be ℘ 0.05.
Publication Details
Page(s) 1287-1298
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 29, Issue: 4, Year: 2016

Request the full text from PASTIC

0

Citations

0

Downloads

63

Views